Abstract
The antiprogestin mifepristone has been used for more than 20 years as a medical alternative for early pregnancy termination. After mifepristone administration, significant changes have been observed in the endometrial vessels, with cell injury and cell death in capillary endothelial cells. In this study, the effect of mifepristone on human endometrial endothelial cells (HEECs) in vitro was evaluated using proliferation and viability assays, quantitative polymerase chain reaction of markers important for the regulation of angiogenesis, and by tube formation assay. There were no detectable effects of mifepristone on HEECs messenger RNA expression of the studied markers. Exposure to mifepristone did not alter tube formation. However, mifepristone exposure to HEECs cocultured with endometrial stromal cells significantly reduced the activity in the tube formation assay compared with mifepristone exposure of HEECs in monoculture. This implies that mifepristone causes changes in HEEC-associated angiogenic activity and that this effect is mediated through stromal cells via paracrine mechanisms.
Similar content being viewed by others
References
Gargett CE, Rogers PA. Human endometrial angiogenesis. Reproduction. 2001;121(2): 181–186.
Iruela-Arispe ML, Rodriguez-Manzaneque JC, Abu-Jawdeh G. Endometrial endothelial cells express estrogen and progesterone receptors and exhibit a tissue specific response to angiogenic growth factors. Microcirculation. 1999;6(2):127–140.
Critchley HOD, Brenner RM, Henderson TA, et al. Estrogen receptor P, but not estrogen receptor a, is present in the vascular endothelium of the human and nonhuman primate endometrium. J Clin Endocrinol Metab. 2001;86(3):1370–1378.
Lecce G, Meduri G, Ancelin M, Bergeron C, Perrot-Applanat M. Presence of estrogen receptor P in the human endometrium through the cycle: expression in glandular, stromal, and vascular Cells. J Clin Endocrinol Metab. 2001;86(3):1379–1386.
Kayisli UA, Luk J, Guzeloglu-Kayisli O, Seval Y, Demir R, Arici A. Regulation of angiogenic activity of human endometrial endothelial cells in culture by ovarian steroids. J Clin Endocrinol Metab. 2004;89(11):5794–5802.
Krikun G, Schatz F, Taylor R, et al. Endometrial endothelial cell steroid receptor expression and steroid effects on gene expression. J Clin Endocrinol Metab. 2005;90(3):1812–1818.
Helmestam M, Stavreus-Evers A, Olovsson M. Cadmium chloride alters mRNA levels of angiogenesis related genes in primary human endometrial endothelial cells grown in vitro. Reprod Toxicol. 2010;30(3):370–376.
Helmestam M, Andersson H, Stavreus-Evers A, Brittebo E, Olovsson M. Tamoxifen modulates cell migration and expression of angiogenesis-related genes in human endometrial endothelial Cells. Am J Pathol. 2012;180(6):2527–2535.
Yasuo T, Kitaya K. Effect of ovarian steroids on gene expression profile in human uterine microvascular endothelial cells. Fertili Sterili. 2009;92(2):709–721.
Toth B, Scholz C, Ochsenkühn R, et al. Effects of progesterone and Its antagonist mifepristone on progesterone receptor a expression in human umbilical vein endothelial cells. Gynecol Obstet Invest. 2009;67(4):269–274.
Wolf JP, Hsiu JG, Anderson TL, Ulmann A, Baulieu EE, GD H. Noncompetitive antiestrogenic effect of RU 486 in blocking the estrogen-stimulated luteinizing hormone surge and the proliferative action of estradiol on endometrium in castrate monkeys. Fertili Sterili. 1989;52(6):1055–1060.
Baird DT, Brown A, Critchley HOD, Williams AR, Lin S, Cheng L. Effect of long-term treatment with low-dose mifepristone on the endometrium. Hum Reprod. 2003;18(1):61–68.
Narvekar N, Critchley HOD, Cheng L, Baird DT. Mifepristone-induced amenorrhoea is associated with an increase in microvessel density and glucocorticoid receptor and a decrease in stromal vascular endothelial growth factor. Hum Reprod. 2006;21(9):2312–2318.
Chwalisz K, Brenner RM, Fuhrmann UU, Hess-Stumpp H, Elger W. Antiproliferative effects of progesterone antagonists and progesterone receptor modulators on the endometrium. Steroids. 2000;65(10–11):741-751.
Slayden OD, Brenner RM. Hormonal regulation and localization of estrogen, progestin and androgen receptors in the endometrium of nonhuman primates: effects of progesterone receptor antagonists. Arch Histol Cytol. 2004;67(5):393–409.
Johannisson E, Oberholzer M, Swahn M-L, Bygdeman M. Vascular changes in the human endometrium following the administration of the progesterone antagonist RU 486. Contraception. 1989;39(1):103–117.
Spitz IM. Mifepristone: where do we come from and where are we going?: Clinical development over a quarter of a century. Contraception. 2009;82(5):442–452.
Meng C-X, Andersson KL, Bentin-Ley U, Gemzell-Danielsson K, Lalitkumar PGL. Effect of levonorgestrel and mifepristone on endometrial receptivity markers in a three-dimensional human endometrial cell culture model. Fertili Sterili. 2009;91(1):256-264.
Sitruk-Ware R. New progestagens for contraceptive use. Hum Reprod Update. 2006;12(2):169–178.
Bredhult C, Backlin B-M, Olovsson M. Effects of some endocrine disrupters on the proliferation and viability of human endometrial endothelial cells in vitro. Reprod Toxicol. 2007;23(4):550–559.
Bredhult C, Sahlin L, Olovsson M. Gene expression analysis of human endometrial endothelial cells exposed to op’-DDT. Mol Hum Reprod. 2008;14(2):97–106.
Bredhult C, Sahlin L, Olovsson M. Gene expression analysis of human endometrial endothelial cells exposed to bisphenol A. Reprod Toxicol. 2009;28(1):18–25.
Moberg C, Catalano RD, Charnock-Jones DS, Olovsson M. VEGF-A and serum withdrawal induced changes in the transcript profile in human endometrial endothelial cells. Reprod Sci. 2010;17(6):590–611.
Arnaoutova I, Kleinman HK. In vitro angiogenesis: endothelial cell tube formation on gelled basement membrane extract. Nat Protoc. 2010;5(4):628–635.
Khoo CP, Micklem K, Watt SM. A comparison of methods for quantifying angiogenesis in the matrigel assay in vitro. Tissue Eng Part C Methods. 2011;17(9):895–906.
Muller PY, Janovjak H, Miserez AR, Dobbie Z. Processing of gene expression data generated by quantitative real-time RT-PCR. Biotechniques. 2002;32(6):1372–1374, 1376, 1378–1379.
Uhlen M, Bjorling E, Agaton C, et al. A Human protein atlas for normal and cancer tissues based on antibody proteomics. Mol Cell Proteomics. 2005;4(12):1920–1932.
Yuhki M, Kajitani T, Mizuno T, Aoki Y, Maruyama T. Establishment of an immortalized human endometrial stromal cell line with functional responses to ovarian stimuli. Reprod Biol Endocrinol. 2011;9(1):104.
Brenner RM, Slayden OD. Steroid receptors in blood vessels of the rhesus macaque endometrium: a review. Arch Histol Cytol. 2004;67(5):411–416.
Chen Y, Wang W, Zhuang Y, Chen X, Huang L. Effects of lowdose mifepristone administration in two different 14-day regimens on the menstrual cycle and endometrial development: a randomized controlled trial. Contraception. 2011;84(1):64–70.
Gargett CE, Lederman FL, Lau TM, Taylor NH, Rogers PAW. Lack of correlation between vascular endothelial growth factor production and endothelial cell proliferation in the human endometrium. Hum Reprod. 1999;14(8):2080–2088.
Arnaoutova I, George J, Kleinman H, Benton G. The endothelial cell tube formation assay on basement membrane turns 20: state of the science and the art. Angiogenesis. 2009;12(3):267–274.
Bamberger A-M, Milde-Langosch K, Loning T, Bamberger CM. The glucocorticoid receptor is specifically expressed in the stromal compartment of the human endometrium. J Clin Endocrinol Metab. 2001;86(10):5071–5074.
Brenner RM, Slayden OD, Nayak NR, Baird DT, Critchley HOD. A role for the androgen receptor in the endometrial antiproliferative effects of progesterone antagonists. Steroids. 2003;68(10–13):1033–1039.
Schatz F, Papp C, Aigner S, Krikun G, Hausknecht V, Lockwood CJ. Biological mechanisms underlying the clinical effects of RU 486: modulation of cultured endometrial stromal cell stromelysin-1 and prolactin expression. J Clin Endocrinol Metab. 1997;82(1):188–193.
Dietrich W, Gaba A, Zhegu Z, et al. Testosterone dependent androgen receptor stabilization and activation of cell proliferation in primary human myometrial microvascular endothelial cells. Fertili Sterili. 2011;95(4):1247–1255.e1-2.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Helmestam, M., Lindgren, K.E., Stavreus-Evers, A. et al. Mifepristone-Exposured Human Endometrial Endothelial Cells In Vitro. Reprod. Sci. 21, 408–414 (2014). https://doi.org/10.1177/1933719113497284
Published:
Issue Date:
DOI: https://doi.org/10.1177/1933719113497284